ATE488507T1 - Platinanaloga mit monoazolligand - Google Patents

Platinanaloga mit monoazolligand

Info

Publication number
ATE488507T1
ATE488507T1 AT06719723T AT06719723T ATE488507T1 AT E488507 T1 ATE488507 T1 AT E488507T1 AT 06719723 T AT06719723 T AT 06719723T AT 06719723 T AT06719723 T AT 06719723T AT E488507 T1 ATE488507 T1 AT E488507T1
Authority
AT
Austria
Prior art keywords
rna
platinum
dna
analogs
replication
Prior art date
Application number
AT06719723T
Other languages
English (en)
Inventor
Zejun Xiao
Harry Kochat
Frederick Hausheer
Original Assignee
Bionumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionumerik Pharmaceuticals Inc filed Critical Bionumerik Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE488507T1 publication Critical patent/ATE488507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
AT06719723T 2005-06-30 2006-01-26 Platinanaloga mit monoazolligand ATE488507T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69563605P 2005-06-30 2005-06-30
PCT/US2006/002998 WO2007005058A2 (en) 2005-06-30 2006-01-26 Monoazole ligand platinum analogs

Publications (1)

Publication Number Publication Date
ATE488507T1 true ATE488507T1 (de) 2010-12-15

Family

ID=37604911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06719723T ATE488507T1 (de) 2005-06-30 2006-01-26 Platinanaloga mit monoazolligand

Country Status (10)

Country Link
US (1) US7759488B2 (de)
EP (1) EP1896491B1 (de)
JP (1) JP5193032B2 (de)
CN (1) CN101495459A (de)
AT (1) ATE488507T1 (de)
AU (1) AU2006266446B2 (de)
CA (1) CA2612710C (de)
DE (1) DE602006018299D1 (de)
MX (1) MX2007015852A (de)
WO (1) WO2007005058A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10384935B2 (en) * 2008-07-07 2019-08-20 Northwestern University Functionalization of carbon nanotubes with metallic moieties
EP3012329B1 (de) 2010-06-18 2017-10-25 Myriad Genetics, Inc. Verfahren und materialien zur bewertung des verlusts der heterozygotie
WO2012027224A1 (en) 2010-08-24 2012-03-01 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
JP6117194B2 (ja) 2011-06-17 2017-04-19 ミリアド・ジェネティックス・インコーポレイテッド アレル不均衡を評価するための方法および材料
BR112014015152A2 (pt) 2011-12-21 2017-07-04 Myriad Genetics Inc métodos e materiais para a avaliação da perda de heterozigosidade
CA2864481C (en) 2012-02-23 2020-07-14 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
WO2013182645A1 (en) 2012-06-07 2013-12-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
AU2014248007B2 (en) 2013-04-05 2020-03-26 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
WO2015086473A1 (en) 2013-12-09 2015-06-18 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
CA2958801A1 (en) 2014-08-15 2016-02-18 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
US10313559B2 (en) * 2014-11-26 2019-06-04 Hp Indigo B.V. Rosette-free printing
EP4141127B1 (de) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Verfahren zur bewertung des mangels an homologer rekombination in eierstockkrebszellen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424739A (en) * 1966-01-19 1969-01-28 Massachusetts Inst Technology Azo-containing organo-metallic complexes
US5107007A (en) * 1989-09-01 1992-04-21 The University Of Vermont And State Agricultural College Bis-platinum complexes as chemotherapeutic agents
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
GB0120618D0 (en) * 2001-08-24 2001-10-17 Univerity Court Of The Univers Photoreactive compounds and compositions
AU2004270655B2 (en) * 2003-08-13 2011-03-24 University Of South Florida Methods for inhibiting tumor cell proliferation

Also Published As

Publication number Publication date
EP1896491B1 (de) 2010-11-17
CA2612710C (en) 2013-05-14
JP5193032B2 (ja) 2013-05-08
JP2009501154A (ja) 2009-01-15
EP1896491A2 (de) 2008-03-12
CN101495459A (zh) 2009-07-29
EP1896491A4 (de) 2009-12-09
US20070004696A1 (en) 2007-01-04
CA2612710A1 (en) 2007-01-11
DE602006018299D1 (de) 2010-12-30
US7759488B2 (en) 2010-07-20
WO2007005058A2 (en) 2007-01-11
WO2007005058A3 (en) 2009-04-16
AU2006266446B2 (en) 2011-03-10
MX2007015852A (es) 2008-02-22
AU2006266446A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
Thomas et al. Gold compounds for catalysis and metal-mediated transformations in biological systems
ATE488507T1 (de) Platinanaloga mit monoazolligand
Yan et al. Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
Lo et al. Utilization of the photophysical and photochemical properties of phosphorescent transition metal complexes in the development of photofunctional cellular sensors, imaging reagents, and cytotoxic agents
Guainazzi et al. Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy
NZ703824A (en) Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell
BR112018013808A2 (pt) dinucleotídeos cíclicos para o tratamento de condições associadas à atividade de sting, tal como câncer
Yadav et al. Intracellular photocatalytic NADH/NAD (P) H oxidation for cancer drug development
MX354256B (es) Derivados de fluoreno, antraceno, xanteno, dibenzosuberona y acridina y usos de ellos.
NO20074856L (no) Transkarotenoide, deres syntese, formulering og anvendelse
WO2011131693A3 (en) Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
CR9749A (es) Derivados de xantina como agonistas de hm74a selectivos
WO2006096754A3 (en) Stabilized aptamers to psma and their use as prostate cancer therapeutics
NO20081045L (no) Forbindelser og fremgangsmater for behandling av cancer
BRPI0608175A2 (pt) método de eliminação de população de células heterogêneas ou mistas em tumores, assim como compostos maitansinóides
JP2008536487A5 (de)
CY1111240T1 (el) Παραγωγα ετεροαρυλουριας χρησιμα για την αναστολη της chk1
AR047574A1 (es) Genes del ciclo celular y metodos de uso relacionados
ZA202207211B (en) Peptide docking vehicle for targeted nucleic acid delivery
AR066690A1 (es) Agentes terapeuticos para canceres resistentes a agentes quimioterapeuticos que incluyen como ingrediente activo un anticuerpo que reconoce hla de clase i y sus usos
Adam et al. Triazolopyridopyrimidines: an emerging family of effective DNA photocleavers. DNA binding. Antileishmanial activity
WO2007015771A3 (en) Composition and method for introduction of rna interference sequences into targeted cells and tissues
WO2007005056A3 (en) Platinum complexes with mononitrile-containing ligands
Shrestha et al. Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin–cholestane hybrid compounds
IN2015KN00569A (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1896491

Country of ref document: EP